Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 180,000,000
    Countries
    Sector(s)
    France : € 10,800,000
    Denmark : € 14,400,000
    Sweden : € 68,400,000
    Germany : € 86,400,000
    Industry : € 180,000,000
    Signature date(s)
    2/10/2020 : € 1,800,000
    2/10/2020 : € 2,400,000
    20/07/2018 : € 9,000,000
    2/10/2020 : € 11,400,000
    20/07/2018 : € 12,000,000
    2/10/2020 : € 14,400,000
    20/07/2018 : € 57,000,000
    20/07/2018 : € 72,000,000

    Summary sheet

    Release date
    2 August 2018
    Status
    Reference
    Signed | 20/07/2018
    20180192
    Project name
    Promoter - financial intermediary
    GETINGE MEDICAL TECHNOLOGY RDI
    GETINGE AB (PUBL)
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 180 million
    EUR 417 million
    Location
    Sector(s)
    Description
    Objectives

    The project consists of research, development and innovation (RDI) investments related to medical technology in the areas of acute care therapies, surgical workplaces and life science during the 2018-2021 period.

    The operation targets the promoter's RDI activities for the development of new or improved products and technologies that contribute to quality enhancement and cost efficiency in healthcare and life sciences.

    Environmental aspects
    Procurement

    The investments are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

    The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - GETINGE MEDICAL TECHNOLOGY RDI
    Publication Date
    13 Mar 2019
    Document language
    Main Topic
    Lending
    Document Number
    83501352
    Document Focus
    Environmental Information
    Project Number
    20180192
    Sector(s)
    Regions
    Publicly available
    Download now
    scoreboard - GETINGE MEDICAL TECHNOLOGY RDI
    Publication Date
    27 Mar 2019
    Document Language
    English
    Main Topic
    lending
    Document Number
    86514060
    Document Focus
    EFSI legal requirements
    Document Type
    Scoreboard
    Project Number
    20180192
    Last update
    27 Mar 2019
    Sector(s)
    Industry
    Countries
    Denmark, France, Germany, Sweden
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications